FK506 and Cyclosporin A Enhance IL-6 Production in Monocytes
Author Information
Author(s): K. Murayama, M. Sawamura, H. Murakami, J. Tamura, T. Naruse, J. Tsuchiya
Primary Institution: Gunma University School of Medicine
Hypothesis
Do FK506 and cyclosporin A influence the production of IL-6 in monocytes at a single-cell level?
Conclusion
FK506 and CsA can selectively enhance IL-6 production in monocytes stimulated with low concentrations of LPS.
Supporting Evidence
- FK506 and CsA enhanced the percentage of IL-6-producing monocytes stimulated with low concentrations of LPS.
- The optimal effect of FK506 was achieved at a concentration 7-fold lower than that of CsA.
- Neither FK506 nor CsA enhanced IL-6 production when monocytes were stimulated with high concentrations of LPS.
- Monocytes produced IL-6 in a dose-dependent manner when stimulated with LPS.
Takeaway
This study found that two drugs, FK506 and CsA, can help certain immune cells make more of a substance called IL-6 when they are given a small amount of a specific trigger.
Methodology
Monocytes were isolated from healthy donors and stimulated with lipopolysaccharide (LPS) in the presence of FK506 or CsA, followed by immunocytochemical detection of IL-6 production.
Potential Biases
Potential bias due to the small sample size and the specific conditions under which the experiments were conducted.
Limitations
The study only examined the effects of FK506 and CsA on IL-6 production at specific concentrations of LPS and did not explore other cytokines extensively.
Participant Demographics
Healthy blood donors were used for monocyte isolation.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website